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In vitro inhibition of Helicobacter pylori and interaction studies of 
lichen natural products with jack bean urease 
Tiago C. A. Lage,a Thamilla Maria S. Maciel,b Yane C. C. Mota,c Francesca Sisto,d José R. Sabino,e 
Josué C. C. Santos,b Isis M. Figueiredo,b Carla Masia,d Ângelo de Fátima,f,* Sergio A. Fernandes,a,* 
Luzia V. Modoloc 
The interaction of (S)-(-)-usnic acid (2) and fumarprotocetraric acid (3), isolated from Cladonia rappii (lichen), and 
commercial (R)-(+)-usnic acid (1) with urease was investigated in vitro by molecular spectroscopy at pH 7.4 and kinetics 
experiments using jack bean type III urease. All lichen compounds tested interact with urease by statistic quenching 
mechanism forming non-fluorescent complexes that change the native protein structure. Complexes formation were 
spontaneous and stabilized mainly by electrostatic forces, in which interaction magnitude was determined to be 3 < 2 < 1. 
Compound 2, whose tridimensional structure is here disclosed, acts as mixed inhibitor while compounds 1 and 3 function 
as competitive ones. The (R)-(+)-UA (1) were the most efficient lichen metabolite with respect to impairment of the 
growth of five H. pylori strains. The minimum inhibitory concentrations (MIC) for the lichen metabolites tested were lower 
(from 2- to 7.8-fold) than those of omeprazole (reference drug) against all H. pylori strains tested. Overall, the lichen 
metabolites 1-3 are promising lead compounds for the design of more efficient urease inhibitors for the treatment of H. 
pylori infections.
Introduction 
 
Lichens are symbiotic organisms formed by green algae or 
cyanobacterium (photobiont portion) and a fungal partner 
(mycobiont). Such relationship is quite complex and provides 
with a fantastic pool of secondary metabolites, mostly due to 
the fungal component.1 The natural compounds produced by 
lichens have been shown to be valuable for medicinal 
purposes.2 Usnic acid (UA; Figure 1), discovered in 1843, is the 
most studied lichen metabolite3 likely due to the fact that both 
enantiomeric forms are unique to lichens and particularly 
abundant in Alectoria, Cladonia, Usnea, Lecanora, Ramalina 
and Evernia  
 
species.4 The UA exhibits a broad variety of biological 
properties, which include antimicrobial,5 antioxidant,6 
antiviral,7 antiproliferative/cytotoxic,7,8 anti-inflammatory9 and 
wound healing10 activities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Secondary metabolites produced by lichens. 
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Fumarprotocetraric acid (FPA; 3) is a depsidone derivative first 
isolated in 1904 from the lichen Cetraria islandica.11 This class 
of compounds was shown to inhibit the HIV-1 integrase 
activity12 and lipid peroxidation, besides functioning as 
expectorant13 and herbicide.14 Substances able to inhibit the 
activity of Helicobacter pylori urease have been used for the 
treatment of diseases associated with infections caused by this 
gram-negative bacterium. The mechanism by which H. pylori 
colonizes the stomach involves the production of urease and its 
release to the medium to increase the pH around bacterial 
microenvironment via conversion of urea to ammonia.15 In 
addition, it is reported that ammonia can also contribute to the 
gastric lesions.16 Then, the development of new urease 
inhibitors has been an interesting approach for the treatment of 
H. pylori-associated diseases. 
This work focused on investigation of the potential of the 
lichen secondary metabolites (R)-(+)-usnic acid (1), (S)-(-)-
usnic acid (2) and fumarprotocetraric acid (3) to inhibit, in 
vitro, urease activity and H. pylori growth. Kinetics studies 
were performed to reveal the mechanism by which these natural 
products inhibit the enzyme. The urease-inhibitor interactions 
were extensively explored by molecular fluorescence assays. 
The X-ray structure of compound 2, herein isolated from the 
lichen Cladonia rappii, is also disclosed. 
 
Results and discussion 
 
Structure elucidation 
 
The (S)-(-)-usnic acid [(S)-(-)-UA (2)] was successfully isolated 
from C. rappii as yellow needles whose molecular formula 
(C18H16O7) was determined on the basis of HRESITOFMS 
analysis (m/z 343.0792, for C18H15O7, [M-H]
-). The melting 
point obtained for compound 2 was 193.7-194.3 oC (Lit.: 200-
201 oC).17 Signal correspondent to the conjugated cyclic ketone 
group was observed at 1688 cm-1 in the infrared spectrum. The 
ketone groups were noted at 1627 cm-1 and 1605 cm-1. The 
antisymmetric and symmetric ν(COC) signals for aryl alkyl 
ethers were assigned at 1283 and 1067 cm-1, respectively.18 The 
signal at 3400 cm-1, typical of −OH groups absorption, was 
absent in the IR spectrum due to the formation of an intra-
molecular hydrogen-bonding, confirmed by X-ray analysis 
(Figure 2). 
The 1H NMR spectra for compound 2 exhibited singlet 
signals only. The most characteristic signal was recorded at δH 
18.84 for the 3-OH hydrogen, with the two other signals at δH 
13.30 (7-OH) and δH 11.02 (9-OH). The signals correspondent 
to carbon atoms bonded to –OH groups were recorded, 
respectively, at δC 191.6, 163.8 and 157.4 in the 
13C NMR 
spectrum. All the spectral data are in agreement with those 
reported elsewhere.18,19 The stereochemistry at C-9b was 
determined to be as (S)-(-) configuration based on the negative 
sign of rotation ([α]20
d = -391) for the isolated usnic acid (2). 
This value presents an opposite sign when compared with the 
reported data for the isomer [(R)-(-)-UA (1)].4,5a 
The compound 2 chirality was also confirmed by X-ray 
Crystallography analysis (Figure 2). The experimental setup 
using Cu-Kα was successful due to the oxygen atoms 
anomalous scattering. In this case, the anomalous signal of an 
oxygen atom is about 5% that of the scattering power of a point 
electron, but the unit cell contains 56 O atoms, because there 
are two independent molecules of 2 in the asymmetric unit 
related by a non-crystallographic 2-fold axis. As a result, the 
anomalous signal of the whole unit cell is comparable to the 
scattering of about 2.8 electrons. The chirality was determined 
with respect to the Flack parameter of 0.026(18), calculated 
using 2266 intensity quotients.20 Besides, an interesting feature 
is the occurrence of a short intramolecular hydrogen bond 
involving the atoms O14-H…O16, with donor-acceptor 
distance of 2.402(2) and 2.403(2) Å, in the molecules A and B, 
respectively. The hydrogen atoms were located and freely 
refined close to the midway. Therefore, the C4−O14 and 
C15−O16 bond distances are in the range from 1.268(2) Å to 
1.286(2) Å. 
Figure 2. Ortep representation of (S)-(-)-usnic acid (2) asymmetric 
unit. Atomic ellipsoids are drawn at 30% of probability level. 
 
The fumarprotocetraric acid [FPA; (3)] was precipitated as an 
amorphous powder of molecular formula equal to C22H16O12 as 
attested by HRESITOFMS (m/z 471.0603, for C22H15O12, [M-H]
-). 
The spectral data are in agreement with those described in the 
literature.18,21 Antisymmetric and symmetric ν(C=C) stretching 
signals were assigned at 3094 cm-1 of IR spectrum. The ν(C=O) for 
phenyl-ester group was at 1747 cm-1. The ν(C=O) frequency for the 
other carbonyl groups in compound 3 was found to be quite lower 
than the expected due to a conjugation of carbonyl groups and 
hydrogen-bonding. Thus, a band for methyl-ester and chain 
carboxylic acid was observed at 1699 cm-1 and at 1655 cm-1 for 
aldehyde and phenyl carboxylic acid. Bands for ν(C=C) were 
registered at 1615 cm-1 and at 1575 cm-1 for ν(C=C) of aromatics.18 
Similarly to the observed for compound 2, 1H NMR spectrum 
exhibited only singlets, indicating the presence of two methyl groups 
singlets at δH 2.42 and 2.45. The methylene (H-9') signal appeared at 
δH 5.30 and δH 6.84 for aromatic hydrogen. The signals for double 
bond hydrogens at 2'' and 3'' were superimposed as a singlet due to 
the same chemical environment at δH 6.64. However, the reaction of 
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FPA (3) with triethylamine produced a salt (3a) (Figure S1; 
Supporting information) that yielded multiplicity of double bound 
signals at δH 6.67, J = 15.6 Hz and δH 6.28, J = 15.6 Hz, 
respectively. The J value indicated that these signals correspond to 
trans double bond. The signal for aldehyde hydrogen was observed 
at δH 10.57. A singlet at δH 11.97 corresponds to the 2'-OH group, 
whose signal appears in a downfield region due to a hydrogen-bond 
and a conjugation with a carboxylic acid. In addition, 13C NMR 
spectrum showed 22 signals: two for methyl carbons (δc 14.6 and 
21.3), one for methylene group (δc 56.8), twelve for two aromatic 
rings, ranging from δc 112.0 to δc 163.9 and two for trans double 
bond carbons (δc 132.1 and 135.0). The signal for the aldehyde 
carbon occurs in δc 191.6 and carbonyl carbons were confirmed by 
signals at δc 170.1 and 165.6, for carboxylic acids, δc 160.9 for 
cyclic ester and δc 164.6 for chain ester. The set of 1H and 13C NMR 
spectra (Figures S2-S6) of compounds 2 and 3 are in the supporting 
information. 
 
Effect of lichen secondary metabolites on urease activity 
 
Purified type III urease from Canavalia ensiformis (jack bean) was 
used to evaluate the ability of lichen metabolites to inhibit the 
ureolytic activity of this hydrolase. The FPA (3) was found to be as 
efficient as hydroxyurea (HU; inhibitor-reference) as it inhibited 
urease activity by 63.7% when used at 1 mM (Figure 3a). At the 
same experimental conditions, (R)-(+)-UA (1) and (S)-(-)-UA (2) 
inhibited the ureolytic activity by 45.3 and 33.1%, respectively. 
Kinetics assays were further performed to determine the mechanism 
by which the lichens metabolites inhibit urease activity. The double-
reciprocal plots indicate that (R)-(+)-UA (1) and FPA (3) are typical 
competitive inhibitors as urea KM increased and urease Vmax was 
unaffected by the presence of these compounds regardless of the 
inhibitor concentration tested (Figures 3b and 3d). On the other 
hand, (S)-(+)-UA (2) works as a mixed inhibitor, in which both KM 
and Vmax were affected in reactions containing increasing 
concentration of inhibitor (Figure 3c). Also, the lines in the double 
reciprocal plot intersect one another in the second quadrant (Figure 
3c). Other natural products such as protocatechuic aldehyde, 
syringaldehyde and vanillin were shown to be mixed inhibitors 
towards urease22. Competitive inhibitors compete with the substrate 
for the enzyme active site and are related to the formation of EI 
(enzyme-inhibitor) complexes whose equilibrium dissociation 
constant (or inhibitor constant) is defined as Ki. Mixed-type 
inhibitors are capable to bind to both the free enzyme, generating EI 
complex, and the enzyme-substrate (ES) complex (providing ESI 
complex), therefore being associated to the additional equilibrium 
dissociation constant K’i. The lower the Ki or K’i is, the higher the 
inhibitor’s affinity for the enzyme active and allosteric(s) sites, 
respectively.23 The affinity of compounds 1 and 3 for urease active 
site was determined to be similar and 3.1-fold higher than that of 
compound 2 (Table 1). As for the mixed inhibitor (S)-(+)-UA (2), its 
affinity for allosteric site(s) was found to be 2.5-fold lower when 
compared to that for urease active site (Table 1). 
 
 
Figure 3. Effect of lichen metabolites on the activity of jack bean urease. For the screening assay (a), enzyme activity was assessed from reactions containing 
1 mM compound-test, 10 mM urea and jack bean type III urease (12.5 mU). As for the kinetics assay, increasing concentrations of urea were incubated for 
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10 min with urease in the absence of inhibitor (I-free) or presence of (R)-(+)-UA (1) (b), (S)-(-)-UA (2) (c) or FPA (3) (d) at indicated concentrations. When 
applicable, hydroxyurea (HU) was used as reference of urease inhibitor. 
 
 
 
Table 1. Effect of lichens secondary metabolites on jack bean urease 
kinetics. Urea (1 to 32 mM) was incubated for 5 min with jack bean 
type III urease in the absence or presence of compounds tested at 0.2, 
0.4 or 0.8 mM. The KM and Vmax values averaged 7.3 ± 1.2 mM and 10.0 
± 0.6 µmol NH4
+ min-1 mg-1 urease, respectively. 
 
Urease inhibitor Ki (mM) K’i (mM) 
(R)-(+)-UA (1) 0.36 ± 0.11 N/A 
(S)-(-)-UA (2) 1.10 ± 0.54 2.94 ± 1.71 
FPA (3) 0.34 ± 0.05 N/A 
Ki refers to as the equilibrium dissociation constant for urease-inhibitor 
(EI) complex and K’i corresponds to the equilibrium dissociation 
constant for urease-urea-inhibitor (ESI) complex. Values are the mean 
± standard error. N/A, not applicable. 
 
Interaction between lichen secondary metabolites and 
jack bean urease 
 
The interaction studies between compounds 1-3 and urease 
were carried out to explore the mechanism of enzyme inhibition 
exhibited by the lichen natural products. Proteins that usually 
present tryptophan (Trp), tyrosine (Tyr) and phenylalanine 
(Phe) residues have intrinsic fluorescence. The Phe residues 
exhibit low fluorescence quantum yield, while that of Tyr ones 
is almost completely quenched by carboxyl groups, disulfide 
bonds or Trp.24 Urease from Canavalia ensiformis (jack bean) 
contains four Trp residues at positions 495, 648, 708, and 728.25 
The urease intrinsic fluorescence is roughly a result of Trp 
residues contribution, which then can be used as intrinsic 
fluorophores for studies of protein-ligand interactions and 
ligand-induced conformational changes around binding site.26 
The interaction between urease and lichen compounds 1-3 
was assessed by stationary fluorescence spectroscopy based on 
quenching effect. The variation of urease fluorescence intensity 
upon addition of (R)-(+)-UA (1) (a competitive inhibitor) is 
shown in Figure 4a. The Trp residue is known to have high 
sensitivity to the microenvironment polarity.24 The maximum 
emission observed at 334 nm for the native urease indicates that 
Trp residues are partly protected from the solvent.27 The blue 
shift of urease fluorescence maximum emission from 334 to 
332 nm could be related to conformational changes induced by 
the interaction of (R)-(+)-UA (1) with urease (Figure 4a). This 
indicated that a decrease of microenvironment polarity around 
Trp residues took place.24,27 Similar results were observed for 
(S)-(-)-UA (2) associated in which the blue shift was from 334 
to 333 nm. Fumarprotocetraric acid (3), however, presented red 
shift from 334 to 335 nm due to increase of microenvironment 
polarity around Trp residues. 
The Stern-Volmer equation was then used to examine the 
mechanism of interaction between lichen compounds 1-3 and 
urease: 
0
SV
F
1 K [Q]
F
= +                                                             equation (1) 
where, F0 and F are the fluorescence intensities in absence and 
presence of the ligands, respectively; [Q] is the ligand 
(quencher) concentration and KSV is the Stern-Volmer 
quenching constant.29,30 The binding constant (Kb) was 
calculated according to equation 2:  
0
b
F - F
log = logK + log[Q]
F
n
 
  
                 equation (2) 
Kb is the binding constant, n is the number of binding sites. The 
equations (1) and (2) were then linearized to obtain the plots of 
Figures 4b and 4c, respectively, to determine KSV, Kb and n 
values.30 
 
 
Figure 4. Urease (1.0 μM) emission spectral profile in the presence of 
different concentrations of (R)-(+)-UA (1) at pH 7.4 and 30 oC (a). Stern-
Volmer quenching plot (b). The inset corresponds to microenvironment 
polarity around Trp residues the linear plot. Double logarithmic curve for 
binding constant calculation (c). 
 
The temperature effect on the interaction between lichen 
compounds 1-3 and urease was further investigated and the results 
summarized in Table 2. The exponential profile of KSV plot (Figure 
4b) indicates that either all Trp residues are accessible to the 
quencher or one of Trp residues is solely responsible for light 
emission.27 The concentration liner range obtained when using 
lichen compounds from 1.0 to 30 µM was employed to calculate KSV 
values (Table 2) and determine mechanism of preferential 
quenching. The KSV values decreased upon increment of 
temperature, indicating the occurrence of static quenching, as higher 
temperatures affect the protein-ligand complex stability31 (Table 2). 
On the other hand, increment in KSV values accompanied of 
increasing in temperature would lead to typical dynamic quenching 
due to larger diffusion coefficient values.  
The ligand affinity toward urease is a relevant parameter for 
protein-ligand interaction studies and thereby helps to understand the 
mechanism by which compounds 1-3 inhibit urease activity. The 
binding constant (Kb) expresses the strength of interaction between a 
ligand and a due protein and for the case of lichen metabolites it was 
found that the interaction between (R)-(+)-UA (1) and urease was 
stronger than that of (S)-(-)-UA (2) and FPA (3) (Table 2). The 
Kb values for lichen compounds 1-3 toward urease were in the same 
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range of those reported for the interaction between 
pentachlorophenol (3.85×103 M-1 at 32 oC),26 K2Cr2O7 (1.96×10
4 M-1 
at 29 oC)31 and Cu(II) (3.89×105 M-1 at 37 oC for [Cu(II)] < 16 µM)32 
and jack bean urease. However, these authors did not evaluate the 
potential of pentachlorophenol, K2Cr2O7 and Cu(II) as urease 
inhibitors. 
Indeed, (R)-(+)-UA (1) interacted more effectively with 
urease likely due to this ability to fit well into urease active site. 
This result is supported by kinetics one in which (R)-(+)-UA (1) 
was determined to be a competitive inhibitor (Figure 3; Table 
1). Urease was found to be enantioselective for usnic acid 
isomers as the Kb values for (R)-(+)-UA (1) were greater than 
those for (S)-(-)-UA. Other enantioselective proteins are 
described in the literature. For instance, human serum albumin 
(HSA) was shown be enantioselective to (R)-ibuprofen (anti-
inflammatory agent)33 and (S)-diclofop-methyl (pesticide).34 
Therefore, Kb value allows establishing whether a protein is 
enantioselective to a certain isomer. Additionally, the Ki values 
obtained from kinetics assay at 25 oC revealed that the affinity 
of (R)-(+)-UA (1) to urease active site is 3-fold higher than that 
of (S)-(+)-UA (1) (Table 1). Similar results were obtained for 
Kb whose value at 23 
oC for the former was 2.9-fold greater 
than that for the latter (Table 2). 
Similarly, to the observed for KSV values, the binding constants 
(Kb) for lichen compounds 1-3 toward urease decreased with 
increment of temperature, confirming the occurrence of static 
quenching. According to equation 2, n corresponds to the number of 
occupied sites by the ligand in the urease structure. The n values 
varied from 0.92 to 1.42, indicating that the interactions among these 
ligands and urease occurs in the ratio of 1:1. 
Thermodynamic parameters (∆H and ∆S) were then obtained 
using the linearized Van’t Hoff equation (equation 3) from 
interaction assays performed at different temperatures.35 These 
parameters permit to deduce the type of forces involved in urease-
inhibitor interaction (Table 2). The Gibbs free energy (∆G) was 
calculated according to equation 4. 
b
∆H 1 ∆S
lnK = - + 
R T R
 
  
 .
            equation (3) 
∆G = ∆H - T∆S             equation (4) 
where T is the temperature in Kelvin (K) and R is the ideal gas 
constant (8.314462 J K-1 mol-1). The Figure S7 (Supporting 
information) shows a graphical representation of linearized Van’t 
Hoff equation (supporting information).
 
Table 2. Binding and thermodynamics parameters for urease interaction with lichen compounds 1-3. 
Lichen compound 
T  
(oC) 
Binding parameters  Thermodynamic parameters 
KSV  
(104 M-1) 
r 
 Kb  
(105 M-1) 
n r 
∆G 
(kJ mol-1) 
∆H 
(kJ mol-1) 
∆S 
(J mol-1) 
(R)-(+)-UA (1) 
23 5.25 ± 0.18 0.9948  52.5 ± 3.7 1.41 ± 0.07 0.9898  -65.70 
-54.81 +36.73 30 5.05 ± 0.16 0.9955  35.5 ± 4.9 1.42 ± 0.06 0.9823  -65.96 
38 4.60 ± 0.17 0.9936  18.6 ± 2.4 1.32 ± 0.07 0.9862  -66.23 
(S)-(-)-UA (2) 
23 5.48 ± 0.30 0.9870  18.3 ± 4.2 1.30 ± 0.09 0.9836  -35.58 
-21.02 + 49.10 30 4.86 ± 0.28 0.9848  15.7 ± 4.5 1.29 ± 0.08 0.9804  -35.92 
38 5.00 ± 0.28  0.9859  12.3 ± 4.4 1.27 ± 0.07 0.9795  -36.30 
FPA (3) 
23 3.29 ± 0.18 0.9861  0.28 ± 0.01 0.96 ± 0.02 0.9955  -25.24 
-14.28 + 36.98 30 3.52 ± 0.19 0.9871  0.25 ± 0.01 0.95 ± 0.01  0.9979  -25.50 
38 3.81 ± 0.23 0.9830  0.21 ± 0.01 0.92 ± 0.02 0.9978  -25.78 
The negative values obtained for ∆G indicate that the interaction 
between lichen compounds 1-3 and urease is thermodynamically 
spontaneous. The possible scenarios for the relationship amongst the 
main forces involved in urease-inhibitor interaction and enthalpy and 
entropy include ∆H > 0 and ∆S > 0 (hydrophobic forces); ∆H < 0 
and ∆S > 0 (electrostatic forces) and ∆H < 0 and ∆S < 0 (hydrogen 
bonding and Van der Waals forces).36 As for the lichen metabolites 
tested, ∆H values were negative, while ∆S ones were positive 
indicating exothermic process and the interaction occurred through 
electrostatic forces. Hence, once urease-inhibitor interaction was 
established, the protein-associated water molecules are displaced by 
the ligand, a condition that was responsible for a positive change in 
entropy system during the interaction. 
The three-dimensional fluorescence spectrum allows obtaining 
more detailed information about typical conformational changes in 
the secondary structure of a protein.30 The three-dimensional 
fluorescence spectra for urease by itself or complexed with (R)-(+)-
UA (1) are presented in Figure 5. Three-dimensional fluorescence 
graphics of free urease and urease-(R)-(+)-UA (1) complex show 
peak 1, which corresponds to Rayleigh scattering, characterized by 
radiation re-emission (λex = λem) from water (solvent) (Figure 5). 
Thereby a small fraction of the absorbed radiation is scattered in all 
directions at a certain wavelength.26 Peak 2 corresponds to the 
emission of Trp and Tyr residues while the emission of polypeptide 
backbone in urease structure stands for peak 3.28 The fluorescence 
intensity of peaks 2 and 3 was reduced by 35 and 74%, respectively, 
by addition of (R)-(+)-UA (Table S1, Supporting information). 
Similar spectral profile was recorded for systems containing (S)-(-)-
UA (2) and FPA (3); reduction of fluorescence intensity of 42 and 
71% was observed for peaks 2 and 3 in medium containing urease 
and 2 while the presence of 3 resulted in 23 and 46% decrease, 
respectively. The main parameters of tridimensional fluorescence are 
listed in Table S1. 
Reduction in fluorescence intensity corresponding to peak 2 
indicated changes in Tyr and Trp microenvironment while 
alterations related to peak 3 stand for modifications in the protein 
native structure. The most significant variations in fluorescence 
intensity were observed when the ligand was added to the medium 
(see peak 3 for reference), which indicates that alterations in 
polypeptide chain and enzyme folding took place.37 At last, these 
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findings are supported by the variation of Stokes shift38 determined 
for native urease and respective inhibitor-enzyme complexes (Table 
S1). 
The synchronous fluorescence is a very sensitivity technique, 
which provides spectral simplification and bandwidth reduction,39 
being useful for assessing changes in the urease microenvironment 
polarity related to Tyr and Trp residues. Stern-Volmer constant 
(KSV) based on ∆λ equal to 15 nm (Tyr) and ∆λ equal to 60 nm (Trp) 
was the parameter employed to investigate urease-lichen metabolites 
interactions. Similar spectra profile was obtained regardless of the 
inhibitor added to the urease-containing system. The spectrum for 
urease in the presence of (R)-(+)-UA (1) is shown in Figure 6 to 
exemplify alterations in the synchronized fluorescence. Synchronous 
fluorescence binding parameters for lichen compounds 1-3 towards 
urease are shown in Table 3. 
The maximum wavelength emission shift for (R)-(+)-UA 
(1) and (S)-(-)-UA (2) towards urease was higher for Trp than 
that of Tyr while no difference was detected for FPA (3)-
containing systems (Figure 6 and Table 3). This is likely due to 
the fact that Tyr residues are less sensitive to the medium 
polarity changes when compared to Trp ones.40 Increase in the 
microenvironment polarity is related to positive variation of 
λmax while polarity reduction is associated to negative variation 
of λmax. These phenomena allow describing changes in the 
structure of native protein. 
 
Figure 5. Tridimensional fluorescence spectra of urease (a) and (R)-(+)-UA 
(1)-urease complex (b) at pH 7.4. Enzyme and ligand were used at 1.0 and 10 
µM, respectively. 
 
 
Figure 6. Urease (1.0 μM) synchronous fluorescence spectra upon addition 
of increasing concentrations of (R)-(+)-UA (1) at different concentrations in 
pH 7.4, monitoring (a) ∆λ equal to 15 nm (Tyr residues) and (b) ∆λ equal to 
60 nm (Trp residues). 
 
Table 3. Synchronous fluorescence binding parameters for lichen 
compounds 1-3 towards jack bean urease. 
 
Lichen compound 
∆λ 
(nm) 
Stern-Volmer parameters λmax emission 
shift (nm)1 KSV r 
(104 L mol-1) 
(R)-(+)-UA (1) 
15 18.61 ± 0.18 0.9938 +1 
60 6.34 ± 0.08 0.9947 - 4 
(S)-(-)-UA (2) 
15 14.94 ± 0.22 0.9939 + 1 
60 6.01 ± 0.11 0.9932 - 2 
FPA (3) 
15 4.81 ± 0.07 0.9923 +1 
60 4.09 ± 0.04 0.9938 +1 
 
1Free urease was used as reference. 
 
Based on KSV values, Tyr residues were systematically more 
affected when compared to Trp ones (Table 3). We hypothesize that 
this is associated with the presence of Tyr at positions 410 and 544 
near to key His residues (409 and 545 positions) known to 
coordinate to Ni atoms in the jack bean urease active site.25,41 The 
Trp residues, such as those at 495 and 648 positions, are far away 
from urease catalytic site, suggesting that Tyr residues had their 
microenvironment changed more significantly than Trp ones. 
Notably, KSV value for Tyr (∆λ = 15 nm) in (R)-(+)-UA (1)-
containing systems was higher that of urease in the presence of 1 
enantiomer (compound 2). This suggests that (R)-(+)-UA (1) 
interacts preferably with urease catalytic site in relation to its 
enantiomer. Indeed, kinetics results indicated that the affinity of 1 to 
urease active site is 3-fold higher than that of 2 (Table 1). 
The influence of substrate (urea) and some classical inhibitors 
(thiourea, hydroxyurea and omeprazole) in the interaction of urease 
with lichen compounds 1-3 was evaluated by competition assay. The 
urease binding constant ratio (Kb’/Kb), in which Kb’ and Kb refer to 
as the binding constant in the presence or absence of a competitor, 
respectively, was used for comparison purpose. Formation of urease-
lichen metabolites complexes is favored when Kb’/Kb > 1 while 
ratios lower than 1 indicate that complex formation is disfavored 
(Table 4).  
 
Table 4. Urease binding constants ratio in the absence (Kb) or presence (Kb’) 
of urease substrate and inhibitors. 
 
Lichen compound 
Competitors (Kb’/Kb) 
Substrate  Inhibitors 
Urea HU1 OMP2 TU1 
(R)-(+)-UA (1) 0.06  0.69 0.06 0.08 
(S)-(-)-UA (2) 0.20  0.87 0.13 0.17 
FPA (3) 0.02  2.63 0.03 0.04 
 
Kb’ = binding constant in the presence of 25 µM substrate or inhibitor, 1.0 µM urease 
and lichen compounds 1-3 (1.0-80 µM). HU, hydroxyurea; OMP, omeprazole and TU, 
thiourea. Inhibitors classification: 1competitive and 2non-competitive. 
 
In general, the binding constant decreases in the presence of 
substrate or inhibitor (Kb’/Kb < 1), indicating that compounds 
interact with urease active site. This result is in agreement with those 
of synchronous fluorescence (Figure 6; Table 3). All compounds 
tested competed with urea for urease active site. Both thiourea and 
hydroxyurea are competitive inhibitors.42 Thiourea, however, was 
determined to be an inhibitor more effective than hydroxyurea. 
Besides, hydroxyurea increased FPA (3) interaction with urease. 
This behavior may be related to the ability of urease to catalyze 
hydroxyurea hydrolysis, even at a low extent.43 Omeprazole is a 
urease proinhibitor (non-competitive) used for the treatment of 
Helicobacter pylori-associated diseases. It is classified as a non-
competitive inhibitor by reacting with free Cys592 residue of jack 
bean urease, which causes blockage of urea access to the enzyme 
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catalytic site.44 The results herein presented (decreased Kb values) 
show that omeprazole effectively prevented lichen compounds 1-3 
from binding to urease. 
The (S)-(-)-UA (2) bound to urease and inactivated it by 
inducing the formation of enzyme aggregates via blockage of 
essential ‒SH groups.45 It is claimed that ‒SH groups blockade was 
achieved through a nucleophilic addition into the carbonyl bond at 
C1 of usnic acid (Figure 1), a condition that can be reversed in the 
presence of Cys or dithiothreitol.46 The mechanism of partial 
inactivation and reactivation of urease by (S)-(-)-UA (2) seems to be 
similar to that of omeprazole.44b Indeed, the kinetics and interaction 
profiles for (S)-(-)-UA (2) revealed that this lichen metabolite is a 
typical mixed inhibitor. Additionally, the urease enantioselectivity 
towards (R)-(+)-UA (1) may be attributed to the spatial configuration 
of ‒CH3 at C9b (Figure 1) that prevents 1 from reacting with Cys592 
residue and consequently being eligible to bind to the active site 
solely. Finally, (R)-(+)-UA (1) interacts preferably with urease 
active site by electrostatic forces as demonstrated by 
kinetics/interaction assays in a manner compared with other already 
reported for known urease inhibitors (Figure 7). 
a)
d)
b)
c)
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Figure 7. Schematic representation of the active site of native jack bean 
urease (a)46 and its interaction with hydroxyurea (b),47 omeprazole after 
reaction with Cys residue (c)44a or (R)-(+)-UA (1) (d; proposed model). W1-
W3, water molecules in the active site; WB, bridging water (hydroxide form). 
The residues Tyr410 and Tyr544, which do not belong to urease active site 
were affected by the interaction process as attested by synchronous 
fluorescence assays. 
 
Effect on Helicobacter pylori growth 
 
The potential of lichen secondary metabolites to inhibit urease 
activity prompted us to investigate whether compounds 1-3 would be 
able to compromise H. pylori growth. This is because the success of 
H. pylori survival in stomach (very acidic environment) relies on its 
relatively high urease activity48 and this bacterial infection is a 
matter of public health. The (R)-(+)-UA (1) was the most efficient 
compound against the bacterial strains tested, except for the 
reference strain NCTC11637 and clinical strain R40/442, whose 
potency was comparable to that of (S)-(-)-UA (2). The MIC values 
for compound 1 were 3.8- to 7.8-fold lower than those for 
omeprazole (OMP; reference drug) and 74- to 286-fold lower than 
those for hydroxyurea (HU) or thiourea (TU), known urease 
inhibitors (Table 5). Likewise, the other lichen natural products (2 
and 3) were more potent than the reference drug or urease inhibitors 
tested. Compound 2 was 2-4-fold more efficient than OMP, 25-99-
fold more efficient than HU and 39-154-fold more potent than TU, 
while the potency for compound 3 was up to 2.7-fold, 25-99-fold 
and 52-104-fold, respectively. Overall, the order of potency for H. 
pylori growth inhibition is 1 > 2 > 3 > OMP > HU > TU (Table 5). 
These results are in agreement with those of jack bean urease‒
inhibitors interaction and kinetics as well. It is noteworthy that the 
active site of jack bean and H. pylori ureases shares similarities 
(Figure S8, Supporting information) although the latter is constituted 
of two subunits while the former possesses a single amino acid 
chain.41 Therefore, the allosteric site(s) targeted by (S)-(-)-UA (2) 
may be distinct from each other between the two ureases. 
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Table 5. Minimal inhibitory concentration MIC (µM and µg mL-1) of lichen secondary metabolites necessary to inhibit Helicobacter pylori growth.  
 
Bacterial strain* (R)-(+)-UA (1) (S)-(-)-UA (2) FPA (3) HU OMP TU 
190 0.012 (4) 0.046 (16) 0.068 (32) 1.683 (128) 0.093 (32) 3.550 (256) 
E17 0.012 (4) 0.023 (8) 0.034 (16) 1.683 (128) 0.093 (32) 3.550 (256) 
23 0.023 (8) 0.046 (16) 0.068 (32) 3.366 (256) 0.185 (64) 3.550 (256) 
110 R 0.012 (4) 0.023 (8) 0.034 (16) 3.366 (256) 0.046 (16) 0.887(64) 
1NCTC 11637 0.023 (8) 0.023 (8) 0.068 (32) 3.366 (256) 0.093 (32) 3.550 (256) 
R40/499 0.012 (4) 0.023 (8) 0.034 (16) 3.366 (256) 0.046 (16) 3.550 (256) 
R40/442 0.023(8) 0.023 (8) 0.034 (16) 3.366 (256) 0.093 (32) 3.550 (256) 
 
Hydroxyurea (HU), omeprazole (OMP) and thiourea (TU) were used as reference of urease inhibitors. 1Reference strain. 
 
*Six clinical isolates of H. pylori and a reference strain were tested. The MIC values were determined by broth microdilution assay in which samples were serially diluted (2-fold) in 96-well microtiter 
plates containing 0.1 mL of RPMI Mega Cell supplemented with 3% FCS. Values outside parentheses correspond to µM while those between parentheses refer to as the corresponding µg mL-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 8 of 13New J urnal of Che istry
N
ew
Jo
ur
na
lo
fC
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
P
u
b
l
i
s
h
e
d
 
o
n
 
1
3
 
F
e
b
r
u
a
r
y
 
2
0
1
8
.
 
D
o
w
n
l
o
a
d
e
d
 
b
y
 
F
u
d
a
n
 
U
n
i
v
e
r
s
i
t
y
 
o
n
 
1
4
/
0
2
/
2
0
1
8
 
1
5
:
5
2
:
1
9
.
 
View Article Online
DOI: 10.1039/C8NJ00072G
  
ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 9  
Please do not adjust margins 
Please do not adjust margins 
Conclusions 
 
In summary, herein it is described the isolation and structure 
elucidation of three secondary metabolites from the lichen 
Cladonia rappii reported for the first time at Serra do 
Brigadeiro State Park in Brazil. Compounds 1-3 effectively 
inhibited the ureolytic activity of jack bean urease with 
mechanisms of action typical of competitive (1 and 3) or 
mixed-inhibitor. They interact with urease by a statistic 
quenching mechanism with formation of non-fluorescent 
complexes in which the native protein structure was altered. 
The complexes were spontaneously formed and mainly 
stabilized by electrostatic forces according to the following 
order of strength: (R)-(+)-UA (1) > (S)-(-)-UA (2) > FPA (3). 
The lichen secondary metabolites were more effective than the 
reference drug OMP on inhibiting H. pylori growth likely due 
to their ability to inhibit urease. Therefore, (R)-(+)-UA (1) > 
(S)-(-)-UA (2) > FPA (3) may comprise excellent prototypes 
for further developing novel agents for the treatment of H. 
pylori-related infections. 
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Experimental section 
 
General experimental procedures  
 
Melting points (uncorrected) were determined in a 
Microquímica MQRPF-301 apparatus. Optical rotation was 
measured on a Perkin Elmer 341 polarimeter. The IR spectrum 
was acquired using a Varian 660-IR gladATR spectrometer. 
NMR spectra were acquired on a Varian Mercury 300 MHz 
spectrometer using residual solvent signal as an internal 
standard. A high-resolution mass spectrum was acquired on a 
Shimadzu LCMS-IT-TOF spectrometer. The single crystal x-
ray structure of compound (2) was determined at vaporized N2 
temperature of 150(2) K using a Bruker-AXS Kappa Apex II 
Duo diffractometer operating with Cu-Kα from a IµS micro-
source, filtered by multi-layer mirror x-ray optics. Structure 
solution was obtained using Direct Methods implemented in 
SHELXS and the final refinement was performed with full 
matrix least squares on F2 using SHELXL. The softwares 
ORTEP-349 and SHELXS/SHELXL50 were used from 
WinGX51 package. Column chromatography was performed on 
silica gel 60 (53-200 µM). Fractions were monitored by TLC, 
and spots were visualized by heating plates with a solution of 
acid vaniline. Vacuum liquid chromatography52 was performed 
using a 2 L sintered funnel and silica gel 60 (53-200 µM). 
 
Lichen material 
 
Cladonia rappii A Evans was harvested in July (2012) at Serra do 
Brigadeiro State Park located in Araponga, Minas Gerais, Brazil 
(20°41’26.85’’S, 42°28’20.41’’W, 1644 m). The lichen species was 
identified by Dr. Suzana M. A. Martins from the Natural Sciences 
Museum of Rio Grande do Sul (Pelotas, RS, Brazil) and deposited in 
the herbarium of the Department of Botany at the Federal University 
of Viçosa (MG, Brazil) under the voucher specimen number VIC 
35,603. The Cladonia rappii harvesting for this study was authorized 
by the Brazilian National Council for Scientific and Technological 
Development (CNPq; process # 010026/2014-2). 
 
Isolation of secondary metabolites from the lichen 
 
Powdered and dried lichen (84.7 g) was extracted with acetone (600 
mL) at room temperature for seven days. The acetone extract was 
filtered and evaporated under reduced pressure to afford the crude 
extract (12.46 g), which was resuspended in hot acetone:ethanol 20:1 
and maintained overnight at -10oC to yield a yellow precipitate 
referred to as the crude usnic acid (UA). Recrystallization with 
acetone/ethanol 95% (5:1) afforded yellow needles of compound 2 
(3.60 g, 4.2%). After that, the remainder crude extract was 
evaporated under reduced pressure, resuspended in hot 
acetone:chloroform 20:1 and kept at -10 oC for 24 h to furnish a grey 
precipitate determined to be a crude fumarprotocetraric acid (FPA; 
3). The suspension was filtered and the precipitate was washed with 
Page 9 of 13 New Journal of Che istry
N
ew
Jo
ur
na
lo
fC
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
13
 F
eb
ru
ar
y 
20
18
. D
ow
nl
oa
de
d 
by
 F
ud
an
 U
ni
ve
rs
ity
 o
n 
14
/0
2/
20
18
 1
5:
52
:1
9.
 
View Article Online
DOI: 10.1039/C8NJ00072G
ARTICLE Journal Name 
10 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
chloroform (3x10 mL) and acetone (3x20 mL) to afford 3 (2.33 g, 
2.75%) as a pure pale grey powder. The (R)-(+)-UA (1) was 
purchased from Sigma-Aldrich. 
 
Derivatization of fumarprotocetraric acid [FPA (3)] 
 
One drop of triethylamine was added directly into an NMR tube 
containing a solution of FPA (3; 6 mg / 600 µL, DMSO-d6). After 
10 min, the NMR tube was shaked for recording the 1H NMR 
spectrum of triethylamine salt obtained.21 
 
(S)-(-)-Usnic acid [(S)-(-)-UA (2)] 
 
Yellow, needle-shaped crystals; Mp 193.7-194.3 oC; [α]20
d = -391.0 
(c 0.7, CHCl3); IR (neat) νmax 1627, 1605, 1283 e 1067 cm
-1; 1H 
NMR (300 MHz, CDCl3) δ 18.84 (1H, s, OH-3), 13.30 (1H, s, OH-
7), 11.02 (1H, s, OH-9), 5.97 (1H, s, H-4), 2.66 (3H, s, 6-OCCH3), 
2.65 (3H, s, 2-OCCH3), 2.08 (1H, s, H-8), 1.75 (1H, s, H-9b); 
13C 
NMR (75 MHz, CDCl3) δ 201.7 (2-OCCH3), 200.3 (6-OCCH3), 
198.0 (C-1), 191.6 (C-3), 179.3 (C-4a), 163.8 (C-7), 157.4 (C-9), 
155.1 (C-6a), 109.2 (C-8), 105.2 (C-2), 103.9 (C-9a), 101.4 (C-6), 
98.3 (C4), 59.0 (C-9b), 32.1 (C-9b), 31.3 (6-OCCH3), 27.9 (2-
OCCH3), 7.5 (C-8); HRESITOFMS m/z 343.0792 [M-H]- 
(Calculated for C18H15O7, m/z 343.0817). Figures S2 and S3 
presented the 1H and 13C NMR spectra, respectively (Supporting 
information). 
 
Fumarprotocetraric acid [FPA (3)] 
 
Pale, grey and amorphous powder; IR (neat) νmax 3094, 1747, 1699, 
1655, 1615, 1575, 1155 cm-1. 1H NMR (300 MHz, DMSO-d6) δ 
11.97 (1H, s, H-7’ or H-4’’ or OH-2’ or OH-4), 10.57 (1H, s, H-9), 
6.84 (1H, s, H-5), 6.64 (2H, s, H-2’’, H-3’’), 5.30 (2H, s, H-9’), 2.45 
(3H, s, H-8), 2.42 (3H, s, H-8’); 13C NMR (75 MHz, DMSO-d6) δ 
191.6 (C-9), 170.1 (C-7’), 165.2 (C-4’’), 164.6 (C-1’’), 163.9 (C-2), 
163.9 (C-4), 160.9 (C-7), 155.3 (C-2’), 152.0 (C-6), 145.4 (C-4’), 
142.1 (C-5’), 135.0 (C-3’’), 132.2 (C-2’’), 131.9 (C-6’), 116.8 (C-5), 
117.2 (C-1´), 113.3 (C-3’), 112.1 (C-3), 112.0 (C-1), 56.8 (C-9’), 
21.3 (C-8), 14.6 (C-8’). HRESITOFMS m/z 471.0603 [M-H]- 
(Calculated for C22H15O12, m/z 471.0566). Figures S4 and S5 
presented the 1H and 13C NMR spectra, respectively (Supporting 
information). 
 
Fumarprotocetraric acid triethylamine salt (3a) 
 
1H NMR (300 MHz, DMSO-d6) δ 10.40 (1H, s, H-9), 6.63 (1H, d, J 
= 15.6 Hz, H-3’’), 6.24 (1H, d, J = 15.6 Hz, H-2’’), 6.08 (1H, s, H-
5), 5.14 (2H, s, H-9’), 2.52 (1H, s, H-8’), 2.48 (1H, s, H-8). Figure 
S6 presented the 1H NMR spectrum (Supporting information). 
 
Urease activity assay 
 
The potential of compounds 1-3 to inhibit the activity of jack bean 
type III urease was investigated essentially as described elsewhere53 
using hydroxyurea as reference of inhibitor and all compound-test at 
1 mM. Buffered reactions (pH 7.0) containing increasing 
concentration of urea (1 to 32 mM), 12.5 mU jack bean type II 
urease and each inhibitor (individually) at fixed concentrations (0.2, 
0.4 or 0.8 mM) were performed to assess the mechanism by which 
compounds 1−3 inhibit the ureolytic activity of urease. Jack bean 
urease kinetic parameters such as initial velocity (Vo), KM 
(Michaelian constant) and maximum velocity (Vmax) were obtained 
using Hyper32 software (hyper32.sharewarejunction.com). The 
double reciprocal plots were obtained using the OriginPro8 (Origin 
Lab, Northamptom, MA) software. The α and the α’ values were 
used to calculate the equilibrium dissociation constants for urease-
inhibitor complex (Ki) and for urease-urea-inhibitor complex (K’i).
23 
 
Interaction studies by molecular fluorescence 
 
Stock solutions of Canavalia ensiformis (jack bean) type III urease 
(Sigma-Aldrich) at 10 µM was prepared in 20 mM phosphate buffer 
(pH 7.4) while the lichen compounds 1-3 were dissolved in DMSO 
to yield 1.0 mM solutions that were further diluted in phosphate 
buffer to provide the corresponding working solutions. Molecular 
fluorescence titrations were performed using quartz cuvettes of 10 
mm optical path on a Shimadzu spectrofluorimeter (model 5301PC, 
Japan) equipped with xenon lamp (150 W). The urease (1.0 µM) 
fluorescence emission spectra in the absence or presence of lichen 
compounds 1-3 (1 to 80 µM) were recorded from 250 to 450 nm 
employing λex of 280 nm at three temperatures (23, 30, 38 ºC). The 
excitation and emission slits were 5 and 10 nm, respectively. 
Tridimensional fluorescence experiments were performed using 
excitation wavelength in the range from 220-350 nm and fixed 
emission range from 260 to 450 nm. Synchronous fluorescence 
spectra for urease in the absence or presence of lichen compounds 1-
3 were obtained by simultaneous variation of excitation and 
emission monochromators. The difference in the excitation 
wavelength (∆λ) was fixed individually at ∆λ equal to 15 nm and ∆λ 
equal to 60 nm to show solely spectroscopic behavior of Tyr and Trp 
residues, respectively. As for the competitive assay, urease substrate 
(urea) and inhibitors (HU, OMP or TU) were used at the fixed 
concentration of 25 µM in the competitive assay.  
 
Bacterial strains culture 
 
Six clinical isolates of H. pylori, and a reference strain of H. pylori 
(ATCC 43504) were included for this study. The strains were 
maintained at -80 °C in Wilkins Chalgren Broth (Difco, BD, San 
Jose, CA, USA) with 10% (v/v) horse serum (Seromed, Biocrhom, 
Germany) and 20% (v/v) glycerol (Merck, Darmstadt, Germany). 
The strains were subcultured on Columbia agar base (Difco, BD, San 
Jose, CA, USA) supplemented with 10% horse serum and 0.25% 
bacto yeast extract (Difco, BD, San Jose, CA, USA). Plates were 
incubated for 72 h at 37 °C in an atmosphere of 10% CO2 in a gas 
incubator. 
 
Determination of minimum inhibitory concentration (MIC) 
 
The MIC values were determined by modified broth dilution method 
as previously described.54 Briefly, two-fold serial dilution of 
compounds-test were prepared in a 96-well microtiter plate 
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containing 100 µL of MegaCellTM RPMI-1640 medium (Sigma-
Aldrich, ST Louis, MO, USA) supplemented with 3% fetal calf 
serum (FCS). An inoculum equivalent to 1 McFarland standard was 
prepared in Wilkins Chalgren broth and diluted in MegaCellTM 
RPMI-1640 medium containing 3% FCS. Each well was inoculated 
with H. pylori at a final concentration of approximately 5×105 CFU. 
Plates were incubated at 37 °C under microaerophilic conditions 
(10% CO2 in a gas incubator) and examined after 72 h of incubation.  
 
Supporting information 
 
This material is available free of charge via the Internet at 
http://pubs.acs.org.” Information: Figures: The reaction for 
formation triethylamine salt of fumarprotocetraric acid, 1H and 13C 
NMR spectra of lichen compounds 2 and 3, Van't Hoff plot for 
interaction between lichen compounds and urease at different 
temperatures. Table: Tridimensional fluorescence parameters for 
free urease by itself or in the presence of lichen compounds 1-3. 
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